Provided by Tiger Trade Technology Pte. Ltd.

Evaxion Biotech A/S

3.21
-0.0100-0.31%
Volume:2K
Turnover:6.38K
Market Cap:26.77M
PE:-2.95
High:3.24
Open:3.22
Low:3.20
Close:3.22
52wk High:12.15
52wk Low:2.77
Shares:8.34M
Float Shares:5.53M
Volume Ratio:0.14
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0886
EPS(LYR):-1.2027
ROE:-109.86%
ROA:-25.97%
PB:2.81
PE(LYR):-2.67

Loading ...

Evaxion to Use New Preclinical Data to Finalize Antigen Selection for Evx-v1 CMV Vaccine Candidate

Reuters
·
Jul 01

Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop

GlobeNewswire
·
Jul 01

European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading

MT Newswires Live
·
Jun 29

European Equities Traded in the US as American Depositary Receipts Decline Friday

MT Newswires Live
·
Jun 26

European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for Week

MT Newswires Live
·
Jun 12

Evaxion receives Prix Galien UK Award for Best digital health solution

GlobeNewswire
·
Jun 12

European Equities Traded in US as ADRs Rise in Thursday Trading

MT Newswires Live
·
Jun 11

Evaxion Biotech Reports Preclinical Progress for Leukemia Vaccine Candidate

MT Newswires Live
·
Jun 11

Evaxion reports new preclinical data for EVX-04 AML therapeutic vaccine ahead of EHA 2026 poster

Reuters
·
Jun 11

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

MT Newswires Live
·
Jun 08

European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading

MT Newswires Live
·
Jun 03

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Jun 01

European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading

MT Newswires Live
·
May 18

Evaxion plans EVX-04 AML vaccine clinical trial application in H2 2026

Reuters
·
May 12

Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress

GlobeNewswire
·
May 12

Evaxion Biotech (EVAX) Gets a Buy from H.C. Wainwright

TIPRANKS
·
May 11

Evaxion Biotech Signals Strong R&D Momentum Amid Cash Constraints

TIPRANKS
·
May 11

Michael Okunewitch Initiates Buy on Evaxion, Citing Strong Clinical Data, AI-Driven Vaccine Platform, and Cash Runway to 2H 2027

TIPRANKS
·
May 09

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 09

European Equities Traded in the US as American Depositary Receipts Rise Friday

MT Newswires Live
·
May 08